Sangeetha Reddy (@smreddymd) 's Twitter Profile
Sangeetha Reddy

@smreddymd

Breast cancer medical oncologist, translational researcher and clinical trialist with focus on immunotherapy and the tumor microenvironment

ID: 896574803510935553

calendar_today13-08-2017 03:31:05

370 Tweet

768 Followers

143 Following

MarleenKokLab (@lab_kok) 's Twitter Profile Photo

PD1-blockade back in the game for ER+ breast cancer! 🎊Congrats to PACE trialists. 👏👏Impressive OS for pts treated with avelumab, most important no special tox in contrast to Cm7A8 and abema/pembro. aPD1 vs aPDL1? #sabcs22. #bcsm SABCS

PD1-blockade back in the game for ER+ breast cancer! 🎊Congrats to PACE trialists. 👏👏Impressive OS for pts treated with avelumab, most important no special tox in contrast to Cm7A8 and abema/pembro.  aPD1 vs aPDL1? #sabcs22. #bcsm <a href="/SABCSSanAntonio/">SABCS</a>
Evanthia Roussos Torres, MD, PhD (@roussostorres) 's Twitter Profile Photo

Incredible presentation at #SABCS2022 on InteractPrint by Student Doctor Lily Xu from Isaac Chan, MD, PhD Lab! Stellar mentorship by Dr. Chan to feature this rising star at a general session! Grateful for this incredible collaboration Sangeetha Reddy UTSW Simmons Cancer Center and excited for more to come!

Incredible presentation at #SABCS2022 on InteractPrint by Student Doctor Lily Xu from <a href="/ithinkichan/">Isaac Chan, MD, PhD</a> Lab! Stellar mentorship by Dr. Chan to feature this rising star at a general session! Grateful for this incredible collaboration <a href="/smreddymd/">Sangeetha Reddy</a> <a href="/utswcancer/">UTSW Simmons Cancer Center</a> and excited for more to come!
Sangeetha Reddy (@smreddymd) 's Twitter Profile Photo

We have a post-doc position @utsw available! Please RT and DM me if interested in a position in translational breast tumor immunology and immunotherapy. We're doing very exciting work focused on enhancing antigen presentation. labs.utsouthwestern.edu/reddy-lab #postdocjobs

Sangeetha Reddy (@smreddymd) 's Twitter Profile Photo

We did it! 7 mo of training, 9 days of hiking in the mountains, the hardest thing by far I’ve done to peak Mt Kilimanjaro…soaring above the clouds & making new family along the way…learned anything can be done by going pole pole (slow) one step at a time! An amazing experience!

We did it! 7 mo of training, 9 days of hiking in the mountains, the hardest thing by far I’ve done to peak Mt Kilimanjaro…soaring above the clouds &amp; making new family along the way…learned anything can be done by going pole pole (slow) one step at a time! An amazing experience!
Sangeetha Reddy (@smreddymd) 's Twitter Profile Photo

Excited to share our work with Anna Vilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade! jitc.bmj.com/content/11/5/e…

Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile Photo

Highlighting the important role the innate immune system plays in immunotherapy, Sangeetha Reddy delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast jitc.bmj.com/content/11/5/e…

Highlighting the important role the innate immune system plays in immunotherapy, <a href="/smreddymd/">Sangeetha Reddy</a> delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast jitc.bmj.com/content/11/5/e…
Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo

It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’ Both The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness Great paper ESMO Open Jon Lim, MRCP PhD esmoopen.com/article/S2059-…

soria (@jsoriamd) 's Twitter Profile Photo

The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes & failures of cancer #immunotherapy doi.org/10.1016/j.immu…

The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes &amp; failures of cancer #immunotherapy   doi.org/10.1016/j.immu…
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Tumor Agnostic Approaches to Care: Vivek Subbiah, MD, Joshua Z. Drago, Mia Levy, MD, PhD, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23. MarleenKokLab Sangeetha Reddy AACR @UTHealthSAMDA OncoAlert

Tumor Agnostic Approaches to Care: <a href="/VivekSubbiah/">Vivek Subbiah, MD</a>, Joshua Z. Drago, <a href="/DrMiaLevy/">Mia Levy, MD, PhD</a>, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23. 
<a href="/lab_kok/">MarleenKokLab</a> <a href="/smreddymd/">Sangeetha Reddy</a> <a href="/AACR/">AACR</a> @UTHealthSAMDA <a href="/OncoAlert/">OncoAlert</a>
Naoto T Ueno, MD, PhD (@teamoncology) 's Twitter Profile Photo

After my wonderful experience at MD Anderson Cancer Center, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research.

After my wonderful experience at <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research.
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer Romualdo Barroso, MD PhD Sara Tolaney Nancy Lin, MD @nabihahtayob @emittendorfmd Rinath Jeselsohn Sangeetha Reddy

#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer <a href="/DrRBarroso/">Romualdo Barroso, MD PhD</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/nlinmd/">Nancy Lin, MD</a> @nabihahtayob @emittendorfmd <a href="/RMJesel/">Rinath Jeselsohn</a> <a href="/smreddymd/">Sangeetha Reddy</a>
Qing Zhang (@qingzhanglab) 's Twitter Profile Photo

#AACR25, capturing the last night at AACR grantee award reception along with ⁦UTSW Simmons Cancer Center⁩ colleague ⁦Sangeetha Reddy⁩ ! Managed to take a photo with the one and only ⁦Margaret Foti, PhD, MD (hc)⁩ !Thanks the grant support from ⁦AACR⁩ ⁦KidneyCAN

#AACR25, capturing the last night at AACR grantee award reception along with ⁦<a href="/utswcancer/">UTSW Simmons Cancer Center</a>⁩ colleague ⁦<a href="/smreddymd/">Sangeetha Reddy</a>⁩ ! Managed to take a photo with the one and only  ⁦<a href="/AACR_CEO/">Margaret Foti, PhD, MD (hc)</a>⁩ !Thanks the grant support from ⁦<a href="/AACR/">AACR</a>⁩ ⁦<a href="/kidneycan/">KidneyCAN</a>⁩
Sangeetha Reddy (@smreddymd) 's Twitter Profile Photo

Grateful to have been part of this important work on dual immune checkpoint blockade in metastatic breast cancers! Congrats to all the authors!